High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes

被引:70
|
作者
Shi, MM [1 ]
Myrand, SP
Bleavins, MR
de la Iglesia, FA
机构
[1] Warner Lambert Co, Parke Davis Pharmaceut Res, Genom Pathol Lab, Pathol & Expt Toxicol, Ann Arbor, MI 48105 USA
[2] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
来源
关键词
NAD(P)H quinone oxidoreductase; genotyping; TaqMan;
D O I
10.1136/mp.52.5.295
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-The two electron reduction of quinones to hydroquinones by NAD(P)H quinone oxidoreductase (NQO1) plays an important role in both activation and detoxification of quinone and similarly reactive compounds. A single nucleotide polymorphism at exon 6 leads to an amino acid change at codon 187 from proline to serine. The variant allele has been associated with decreased NQO1 enzyme activity and increased cancer risks. The aim of this study was to develop a rapid genotyping procedure for epidemiological and clinical research into the potential biological and toxicological implications associated with this genetic polymorphism. Methods-A high throughput genotyping method using fluorogenic probes has been developed to screen this single nucleotide polymorphism. This assay utilises the 5' nuclease activity of Tag polymerase in conjunction with fluorogenic TaqMan probes. The TaqMan genotyping procedure was validated by a restriction fragment length polymorphism method and direct sequencing. Results-This method can be used for the rapid screening of known polymorphisms in large populations. In a population of 143 unrelated individuals, Pro/Pro (wildtype), Pro/Ser (heterozygous), and Ser/Ser (mutant) genotypes were 69.2%, 26.6%, and 4.2%, respectively. Conclusions-This genotyping method is highly accurate and could be applied to automated large scale genotyping studies.
引用
收藏
页码:295 / 299
页数:5
相关论文
共 50 条
  • [31] INVOLVEMENT OF NF-KAPPA-B IN THE INDUCTION OF NAD(P)H-QUINONE OXIDOREDUCTASE (DT-DIAPHORASE) BY HYPOXIA, OLTIPRAZ AND MITOMYCIN-C
    YAO, KS
    ODWYER, PJ
    BIOCHEMICAL PHARMACOLOGY, 1995, 49 (03) : 275 - 282
  • [32] Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1
    Siegel, D
    McGuinness, SM
    Winski, SL
    Ross, D
    PHARMACOGENETICS, 1999, 9 (01): : 113 - 121
  • [33] A COMPARISON OF FREE-RADICAL FORMATION BY QUINONE ANTITUMOR AGENTS IN MCF-7 CELLS AND THE ROLE OF NAD(P)H (QUINONE-ACCEPTOR) OXIDOREDUCTASE (DT-DIAPHORASE)
    FISHER, GR
    PATTERSON, LH
    GUTIERREZ, PL
    CHEMICO-BIOLOGICAL INTERACTIONS, 1993, 88 (2-3) : 137 - 153
  • [34] Association of NAD(P)H:Quinone oxidoreductase 1 polymorphism and Alzheimer's disease in Chinese
    Bian, Jian-Tao
    Zhao, Hua-Lu
    Zhang, Zhen-Xin
    Bi, Xiu-Hua
    Zhang, Jun-Wu
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2008, 34 (03) : 235 - 240
  • [35] Single nucleotide polymorphism detection:: allelic discrimination using TaqMan
    McGuigan, FEA
    Ralston, SH
    PSYCHIATRIC GENETICS, 2002, 12 (03) : 133 - 136
  • [36] Association of NAD(P)H:Quinone Oxidoreductase 1 Polymorphism and Alzheimer’s Disease in Chinese
    Jian-Tao Bian
    Hua-Lu Zhao
    Zhen-Xin Zhang
    Xiu-Hua Bi
    Jun-Wu Zhang
    Journal of Molecular Neuroscience, 2008, 34 : 235 - 240
  • [37] Suspension arrays for high throughput, multiplexed single nucleotide polymorphism genotyping
    Armstrong, B
    Stewart, M
    Mazumder, A
    CYTOMETRY, 2000, 40 (02): : 102 - 108
  • [38] Implication of alternative splicing for expression of a variant NAD(P)H:quinone oxidoreductase-1 with a single nucleotide polymorphism at 465C>T
    Pan, SS
    Han, YS
    Farabaugh, P
    Xia, H
    PHARMACOGENETICS, 2002, 12 (06): : 479 - 488
  • [39] Immunohistochemical detection of NAD(P)H:Quinone oxidoreductase in human lung and lung tumors
    Siegel, D
    Franklin, WA
    Ross, D
    CLINICAL CANCER RESEARCH, 1998, 4 (09) : 2065 - 2070
  • [40] NAD(P)H:quinone oxidoreductase1 and NRH:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism
    Jamieson, David
    Wilson, Kerrie
    Pridgeon, Simon
    Margetts, Jane P.
    Edmondson, Richard J.
    Leung, Hing Y.
    Knox, Richard
    Boddy, Alan V.
    CLINICAL CANCER RESEARCH, 2007, 13 (05) : 1584 - 1590